about
High-contrast X-ray micro-radiography and micro-CT of ex-vivo soft tissue murine organs utilizing ethanol fixation and large area photon-counting detectorPulsed lavage cleansing of osteochondral grafts depends on lavage duration, flow intensity, and graft storage conditionQuantitative imaging of 2 nm monolayer-protected gold nanoparticle distributions in tissues using laser ablation inductively-coupled plasma mass spectrometry (LA-ICP-MS)Computed Tomography Imaging of Solid Tumors Using a Liposomal-Iodine Contrast Agent in Companion Dogs with Naturally Occurring Cancer.In vivo small animal micro-CT using nanoparticle contrast agents.Biodistribution and Toxicity of X-Ray Iodinated Contrast Agent in Nano-emulsions in Function of Their Size.Opportunities for new CT contrast agents to maximize the diagnostic potential of emerging spectral CT technologies.Nanopolymersomes with an Ultrahigh Iodine Content for High-Performance X-Ray Computed Tomography Imaging In Vivo.Non-invasive quantitative imaging of hepatocellular carcinoma growth in mice by micro-CT using liver-targeted iodinated nano-emulsions.Functionalizing Nanoemulsions with Carboxylates: Impact on the Biodistribution and Pharmacokinetics in Mice.Comparison of small animal CT contrast agents.Three-dimensional virtual histology enabled through cytoplasm-specific X-ray stain for microscopic and nanoscopic computed tomography.Design and Synthesis of New Sulfur-Containing Hyperbranched Polymer and Theranostic Nanomaterials for Bimodal Imaging and Treatment of Cancer.Micro-computed tomography for non-invasive evaluation of muscle atrophy in mouse models of disease.Advantages and Limitations of Current Techniques for Analyzing the Biodistribution of NanoparticlesCT Imaging of Enzymatic Activity in Cancer Using Covalent Probes Reveal a Size-Dependent Pattern
P2860
Q27323235-F22130E0-9F29-4402-B12C-264BDC871832Q33626668-62D2331B-91CB-41A7-94AD-75C6183BB380Q35958494-4BD54726-71FE-44A7-8CBF-C5C43E5AD11EQ35975280-B4BA0DF5-C643-4A1D-B11C-35A44AF8CF0EQ36245557-863DD107-2F6B-4EF9-9283-449D2D22CE7AQ38824053-16C5409A-75E9-4CE4-AF60-7433D5E22F59Q38952613-792CEDA0-A6CF-4D20-B023-B65034DA25FBQ39039021-5F77D906-6D6F-42C2-9393-45069221A07BQ42636955-0633B5EF-7E62-4B71-8FDB-B7759546BCA3Q46718581-4F5F691C-9FC9-42A3-A555-BE847618AC6CQ47576170-7A72552A-5A27-4A4F-BDBF-791CC3A8518EQ49790322-6843E197-E3F3-4F35-977C-1A756683D03CQ50146486-389197E9-4A9E-46D3-AFCE-54B5007E47F9Q55423762-86EFD7A7-FC36-46B9-85FB-776E0861BBA4Q57181636-FD682200-47F4-42C6-AC30-63288860D462Q58700000-DEC5876D-87DA-4307-83B0-47A21B93BD03
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Contrast agents for preclinical targeted X-ray imaging.
@en
type
label
Contrast agents for preclinical targeted X-ray imaging.
@en
prefLabel
Contrast agents for preclinical targeted X-ray imaging.
@en
P1476
Contrast agents for preclinical targeted X-ray imaging
@en
P2093
Thierry Vandamme
P304
P356
10.1016/J.ADDR.2014.07.013
P407
P577
2014-07-30T00:00:00Z